PRESIDENT

Prof Anthony Costello AM

Executive Director Australian Prostate Centre, Director of Urology, Royal Melbourne Hospital.

Tony is one of the leading prostate specialists internationally and is Professorial Fellow & Head Department of Urology, The Royal Melbourne Hospital, affiliated with Department of Surgery, University of Melbourne. Tony pioneered robotic surgery in Australia, is an invited faculty member of the American Urological Association where annually he teaches aspects of robotic surgery to an international audience, and is also on the Editorial Board of the US publication Journal of Robotic Surgery, the British Journal of Urology and the Journal of Endourology. In 2017 Tony was awarded the prestigious St. Paul’s Medal by the British Association of Urological Surgeons.

 

PROGRAM SECRETARY

Dr Phil Dundee

Royal Melbourne Hospital, Western Health, Peninsula Health, Australian Prostate Centre

Phil is a urologist with a sub-specialty interest in urologic cancers and minimally invasive surgery. He has a particular interest in the management of patients with high risk and metastatic prostate cancer.

 

CLINICAL UROLOGY CO-CONVENORS

Dr Daniel Moon

Urologist, Australian Urology Associates, Peter MacCallum Cancer Centre, Epworth HealthCare

Dr Daniel Moon is a Urologist with subspecialty expertise in prostate cancer diagnosis and management. He served as the inaugural Director of Robotic Surgery at Epworth Healthcare 2012-2017 and remains an Honorary Clinical Senior Lecturer at The University of Melbourne and Monash University. He has performed over 1500 major laparoscopic +/- robotic procedures, published the first Australian series of laparoscopic radical prostatectomy in 2008, performed the first Australian robotic cysto-prostatectomy in 2009, published the largest Australian pyeloplasty series in 2011, and established a robotic partial nephrectomy program at Peter MacCallum Cancer Centre, publishing the first Australian series of this procedure in 2014.

Dr Moon has developed comprehensive training and credentialing documents for surgeons learning robotic surgery, is on the board of the Australian Medical Robotic Academy, and is on the Editorial Board of the British Journal of Urology International.

Associate Professor Nathan Lawrentschuk

MB, BS, PhD, FRACS (Urology)

Nathan is a Urological Surgeon and Urologic Oncologist with appointments at the University of Melbourne, Department of Surgery, Peter MacCallum Cancer Centre and Olivia Newton-John Cancer and Wellness Centre at the Austin Hospital, Melbourne. Nathan is the Director of the EJ Whitten Prostate Cancer Research Centre at Epworth Hospital in Melbourne. He completed a PhD in kidney cancer as well as two additional years of training in robotic, laparoscopic and open cancer surgery at the University of Toronto, Canada at Princess Margaret Hospital, the world’s 5th largest cancer centre obtaining a Society of Urologic Oncology Fellowship. Nathan has a special interest in cancer high-risk surgery of the prostate, kidney, bladder and testis as well as being comfortable with active surveillance of many cancers where appropriate. In addition to his additional specialised qualifications, He has published over 400 peer reviewed papers and book chapters. He is an Associate Editor of the BJU International and the World Journal of Urology editor of its USANZ Supplements whilst he serves on multiple journal editorial boards and speaks at multiple international conferences.

NURSING AND ALLIED HEALTH CO-CONVENORS

Ms Helen Crowe

Prostate Cancer Nurse Practitioner, Australian Prostate Centre, Melbourne, Australia.

Helen has been working in urology for over 20 years, and was instrumental in establishing urology nursing professional organisations in Australia. She is employed in a private urology practice, devoted to prostate cancer, as a Nurse Practitioner and at the Australian Prostate Centre. She has presented nationally and internationally, published and won awards for her work on the nursing management of men with prostate cancer.

Mr David Gray

Urology Nurse Practitioner, A/Prof Jeremy Grummet Urology, Malvern East, Victoria, Australia

Dave is a Urology Nurse Practitioner at the A/Prof Jeremy Grummet Urology and department of Urology, Box Hill hospital Eastern Health. Special interests include men’s health and urological malignancies, particularly prostate cancer. Dave has a Masters of Nursing (Urology and Continence) and completed his Masters of Nursing (Nurse Practitioner) through Flinders Uni in 2016. Unfortunately Dave is also a hopelessly addicted golf tragic.

Dr Jane Crowe

Private General Practitioner & Prostate Cancer Physician

Jane has been working in general practice in metropolitan Melbourne for nearly 30 years. She also started a role as a Prostate Cancer GP in 2011 at the Epworth Hospital (Richmond) and now works at the Australian Prostate Centre (APC). At APC Jane sees men with prostate cancer as part of a multidisciplinary team, especially those on Androgen Deprivation Therapy, to help monitor and manage the side effects. Jane is also involved in teaching the 3rd Year MD Medical students at the University of Melbourne about Cancer in General Practice and is involved in General Practice research. 

TRANSLATIONAL SCIENCE CO-CONVENORS

Associate Professor Niall Corcoran

Director of Translational Research, Australian Prostate Cancer Research Centre Epworth, University of Melbourne and Royal Melbourne Hospital

Dr Corcoran completed his studies (MB BCh BAO) at the University College of Dublin in 1998 and was awarded a PhD from the University of Melbourne in 2006. He is a urological surgeon and research scientist with an interest in the molecular drivers of lethal prostate cancer and novel treatments.

 

A/Prof Chris Hovens

Director of Scientific Research at the Australian Prostate Cancer Research Centre at Epworth Hospital and Royal Melbourne Hospital

A/Prof Hovens is a senior scientific investigator on a number of sponsored prostate cancer clinical research programs within the Department of Urology at the Royal Melbourne Hospital and the Department of Surgery at the University of Melbourne. He has served as Chief Scientific Officer and main scientific advisor for two start up, drug development companies he has co-founded, Velacor Therapeutics Pty Ltd and CCH Pharma Pty Ltd. A/Prof Hovens was awarded a PhD in 1992 for cloning and analysis of the Ryk Receptor Tyrosine Kinase performed at the Ludwig Institute for Cancer Research under the supervision of Drs Andrew Wilks and Ashley Dunn. In 1992, A/Prof Hovens took up a post doctoral position at the Institute for Molecular Biology in Zurich.

In 2001, A/Prof Hovens was promoted to Director of the Prostate Cancer Research Center in the Departments of Urology and Surgery, University of Melbourne. He has also worked on the functional characterization of spread tumour suppressor proteins and made the discovery of a new, tissue-restricted member of the family, Eve-3. His recent work concerns the co-discovery of a small, water soluble inhibitor of the PI3K/Akt pathway which has been extensively characterized in in vitro and in vivo models of prostate and brain cancer.

A/Prof Hovens received $7.5m from the Federal Government with Professor Anthony Costello in 2008 to establish a Research Centre for Prostate Cancer (Australian Prostate Cancer Research Centre at the Epworth Hospital). In 2008, he and Professor Costello have also received a project grant ($460 000) from the Prostate Cancer Foundation of Australia for their Circulating Cells as Biomarkers for Prostate Cancer study. He has more than 55 peer-reviewed articles and 2 Book Chapters.